We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorman Broadb Regulatory News (NBB)

Share Price Information for Norman Broadb (NBB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.75
Bid: 9.00
Ask: 10.50
Change: 0.00 (0.00%)
Spread: 1.50 (16.667%)
Open: 9.75
High: 9.75
Low: 9.75
Prev. Close: 9.75
NBB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of minority interest in NBIMv

5 Oct 2020 07:00

RNS Number : 0225B
Norman Broadbent PLC
05 October 2020
 

Norman Broadbent plc

("Norman Broadbent", the "Company" or the "Group")

Acquisition of minority interest in Norman Broadbent Interim Management Limited

Norman Broadbent (AIM:NBB) - a leading London listed Professional Services firm offering a diversified portfolio of integrated Leadership Acquisition & Advisory Services, announces that, it has agreed to acquire the outstanding minority interest of 25% of Norman Broadbent Interim Management Limited ("NBIM") from Angela Hickmore (the "Seller") for consideration of £135,000 to be satisfied by the payment of the initial cash consideration of £65,000 at completion and the issue of consideration shares value of £70,000.

For the year ended 31 December 2019, NBIM generated Net Fee Income (after interim costs) of £2,235,000 (31 Dec 2016: £191,000) and a resulting profit of £248,000 (31 Dec 2016: £60,000). This evidences the success of the overall Group strategy, and the growth NBIM has achieved since its relaunch in 2016 under Angela Hickmore's leadership.

Following the appointment of Mike Brennan as Norman Broadbent's Group CEO in April 2016, NBIM was relaunched as part of a new strategy to build a broader, more balanced, Professional Services business. Angela Hickmore was appointed as NBIM Managing Director in Q4 2016 with the mandate to grow this part of the business thus providing an additional and high impact service to clients whilst generating high value contractually guaranteed annuity revenue for the Group. NBIM is now established in the Group's key areas of market and functional specialisations and has successfully leveraged the heritage/high-end Norman Broadbent brand. As clients face increasingly complex and immediate challenges, much of NBIM's activity is focused on securing the talents of senior level, high impact Interim professionals to meet short-term highly specialised needs. Unlike many other Interim providers, NBIM does not focus on the transactional/commoditised low margin end of the market.

As the Company already owns 75% of NBIM, the subsidiary's financial information is already fully consolidated into the Group published financial results.

Mike Brennan, Norman Broadbent Group CEO, said: "Angela has played a pivotal role in taking NBIM from being moribund, to something of substance. She has also played - and continues to play - an important role across the Group. Under her leadership, NBIM has grown and impacted positively on the wider Group financially and - critically - in terms of our client proposition. As we streamline the Group and create multi-service, client focussed 'Hubs', the acquisition of this minority interest fully aligns NBIM with the Group. The acquisition also enables Angela, and other senior members of our wider team, to take on more responsibilities across the Group as we move firmly into the next phase of growth."

Angela Hickmore, MD of NBIM, said: "I am delighted that we have successfully closed this chapter on the NBIM growth story - I look forward to many more years of success as we continue to bring the Group together, benefitting our clients and colleagues. Our Group strategy is clear, and I'm eager to work with my many colleagues to successfully execute the next stage in our strategic growth plan."

 

For further information, please contact:

Norman Broadbent plc

 

Mike Brennan/Steve Smith

 

020 7484 0000

 

WH Ireland Limited

 

Adrian Hadden

Jessica Cave

Darshan Patel

Matthew Chan

020 7220 1666

 

About Norman Broadbent plc:

Norman Broadbent plc (AIM: NBB) is a leading Professional Services firm focusing on Talent Acquisition & Advisory Services. Since its formation nearly 40 years ago, The Norman Broadbent Group has developed a portfolio of complementary services centered around Executive Search Solutions, Senior Interim Management, Research & Insight, and Leadership Consulting & Assessment. Unusually, Norman Broadbent is one of the few businesses of its type offering clients integrated Search and Interim Management Solutions. This innovative approach gives clients immediate access to business-critical executive-level Talent, meeting both short and longer-term needs.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQKKQBBBBDDPKK
Date   Source Headline
15th Apr 20243:18 pmRNSNotification of major holdings
8th Apr 202412:11 pmRNSIssue of Equity and Total Voting Rights
3rd Apr 20244:01 pmRNSNotification of major holdings
28th Mar 20247:00 amRNSPosting of ARA & Notice of AGM
27th Mar 20247:00 amRNSFinal Results
26th Mar 20244:07 pmRNSNotification of major holdings
20th Mar 20241:36 pmRNSNotice of Results & Investor Presentation
18th Mar 20244:33 pmRNSNotification of major holdings
18th Mar 20244:04 pmRNSNotification of major holdings
12th Mar 20243:33 pmRNSAIM Rule 17 Schedule Two (g) Update
22nd Jan 20245:32 pmRNSNotification of Major Holdings
16th Jan 20247:00 amRNSTrading Update
21st Nov 202310:06 amRNSNotification of Major Holdings
20th Nov 202310:45 amRNSDirector/PDMR shareholding
15th Nov 20239:54 amRNSNotification of Major Holdings
15th Nov 20239:43 amRNSNotification of Major Holdings
10th Nov 20237:00 amRNSDirector/PCA Dealing
9th Nov 20232:25 pmRNSDirector/PDMR Shareholding
2nd Nov 20238:43 amRNSConversion Of Outstanding Convertible Loan Notes
12th Oct 20237:00 amRNSQ3 2023 Trading Update
10th Oct 202311:03 amRNSNotification of Major Holdings
9th Oct 20237:00 amRNSSurrender and Granting of Options
28th Jul 20237:00 amRNSGrant of Options
24th Jul 20237:00 amRNSInterim Results
11th Jul 20237:00 amRNSH1 2023 Trading Update
30th Jun 20237:00 amRNSSAYE Option Plan & Director Holding
29th Jun 20234:28 pmRNSResult of AGM
5th Jun 20237:00 amRNSPosting of Annual Report and Notice of AGM
1st Jun 20237:00 amRNSDirectorate changes
31st May 20237:00 amRNSFinal Results
22nd May 20237:00 amRNSQ1 2023 Trading Update
19th May 202312:55 pmRNSPartial Repayment of Convertible Loan Note
24th Jan 20237:00 amRNSTrading Update
10th Jan 20237:00 amRNSDirectorate Change
17th Nov 20224:42 pmRNSTR-1: Notification of major holdings
14th Nov 20227:00 amRNSIssue of Equity
1st Nov 20227:00 amRNSUpdate and Change of Board role
10th Oct 20225:30 pmRNSTR-1: Notification of major holdings
31st Aug 20227:00 amRNSDirector Share Purchase
23rd Aug 20227:00 amRNSDirectorate Change
16th Aug 20227:00 amRNSInterim Results
29th Jul 20227:00 amRNSChange of Adviser
20th Jul 20224:08 pmRNSDirector/PDMR Dealing
11th Jul 20227:00 amRNSTrading Update
29th Jun 20223:15 pmRNSDirector/PDMR Shareholding
23rd Jun 202212:14 pmRNSResult of AGM
7th Jun 20228:59 amRNSHolding(s) in Company
25th May 20227:00 amRNSFinal 2021 Results and Notice of AGM
20th May 20225:49 pmRNSIssue of Convertible Loan Notes
11th May 20224:16 pmRNSDirector resignation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.